Cargando…

Flow-Cytometric Monitoring of Minimal Residual Disease in Pediatric Patients With Acute Myeloid Leukemia: Recent Advances and Future Strategies

Minimal residual disease (MRD) by multiparametric flow cytometry (MFC) has been recently shown as a strong and independent prognostic marker of relapse in pediatric AML (pedAML) when measured at specific time points during Induction and/or Consolidation therapy. Hence, MFC-MRD has the potential to r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buldini, Barbara, Maurer-Granofszky, Margarita, Varotto, Elena, Dworzak, Michael N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798174/ https://www.ncbi.nlm.nih.gov/pubmed/31681710 http://dx.doi.org/10.3389/fped.2019.00412

Ejemplares similares

UMAP Based Anomaly Detection for Minimal Residual Disease Quantification within Acute Myeloid Leukemia
por: Weijler, Lisa, et al.
Publicado: (2022)

Diagnostic challenges in acute monoblastic/monocytic leukemia in children
por: Varotto, Elena, et al.
Publicado: (2022)

An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report
por: Maurer-Granofszky, Margarita, et al.
Publicado: (2021)

Phospho-Profiling Linking Biology and Clinics in Pediatric Acute Myeloid Leukemia
por: Schumich, Angela, et al.
Publicado: (2019)

CD21(–) CD27(–) Atypical B Cells in a Pediatric Cohort Study: An Extensive Single Center Flow Cytometric Analysis
por: Corrente, Francesco, et al.
Publicado: (2022)

Epigenetic modifications and targeted therapy in pediatric acute myeloid leukemia
por: Xu, Huan, et al.
Publicado: (2022)

Flow cytometric significance of cellular alkaline phosphatase activity in acute myeloid leukemia
por: Rico, Laura G., et al.
Publicado: (2019)

Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances
por: Cumbo, Cosimo, et al.
Publicado: (2020)

Relevance of flow cytometric categorization and end-of-induction measurable residual disease assessment in pediatric and adult T-lymphoblastic leukemia patients
por: Bommannan, Karthik, et al.
Publicado: (2022)

Relative impact of residual cytogenetic abnormalities and flow cytometric measurable residual disease on outcome after allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia
por: Orvain, Corentin, et al.
Publicado: (2022)

Harmonization of Flow Cytometric Minimal Residual Disease Assessment in Multiple Myeloma in Centers of Polish Myeloma Consortium
por: Krzywdzińska, Agnieszka, et al.
Publicado: (2021)

Flow Cytometric Analysis of Bone Marrow Particle Cells for Measuring Minimal Residual Disease in Multiple Myeloma
por: Jiang, Duanfeng, et al.
Publicado: (2022)

Mutational Landscape of CEBPA in Mexican Pediatric Acute Myeloid Leukemia Patients: Prognostic Implications
por: Molina Garay, Carolina, et al.
Publicado: (2022)

Flow Cytometric Detection of Proliferative Cells in Leukemias
por: Wakita, Atsushi, et al.
Publicado: (1994)

Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment
por: Vega-García, Nerea, et al.
Publicado: (2021)

Pediatric Acute Myeloid Leukemia (AML): From Genes to Models Toward Targeted Therapeutic Intervention
por: Mercher, Thomas, et al.
Publicado: (2019)

Prognostic significance of minimal residual disease detected by a simplified flow cytometric assay during remission induction chemotherapy in children with acute lymphoblastic leukemia
por: Koh, Kyung Nam, et al.
Publicado: (2010)

Retrospective Analysis of the Treatment Outcome in Myeloid Leukemia of Down Syndrome in Polish Pediatric Leukemia and Lymphoma Study Group From 2005 to 2019
por: Czogala, Malgorzata, et al.
Publicado: (2020)

Conditioning Intensity, Pre-Transplant Flow Cytometric Measurable Residual Disease, and Outcome in Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
por: Morsink, Linde M., et al.
Publicado: (2020)

Profiling FLT3 Mutations in Mexican Acute Myeloid Leukemia Pediatric Patients: Impact on Overall Survival
por: Molina Garay, Carolina, et al.
Publicado: (2020)

Corrigendum: Pediatric Acute Myeloid Leukemia (AML): From Genes to Models Toward Targeted Therapeutic Intervention
por: Mercher, Thomas, et al.
Publicado: (2019)

Flow Cytometric Measurement of Blood Cells with BCR-ABL1 Fusion Protein in Chronic Myeloid Leukemia
por: Löf, Liza, et al.
Publicado: (2017)

Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy
por: Mikhailova, Ekaterina, et al.
Publicado: (2022)

Angiogenesis and Minimal Residual Disease in Patients with Acute Myeloid Leukemia
por: Nematollahi, Pardis, et al.
Publicado: (2020)

Molecular Minimal Residual Disease Detection in Acute Myeloid Leukemia
por: Vonk, Christian M., et al.
Publicado: (2021)

Bilateral Orbital Myeloid Sarcomas: A Unique Presentation of Acute Myeloid Leukemia
por: Stephenson, Shane G, et al.
Publicado: (2022)

Acute Myeloid Leukemia in Infants: Biology and Treatment
por: Masetti, Riccardo, et al.
Publicado: (2015)

Flow Cytometric Identification of Hematopoietic and Leukemic Blast Cells for Tailored Clinical Follow-Up of Acute Myeloid Leukemia
por: Weeda, Vera, et al.
Publicado: (2022)

Beyond CD19: Opportunities for Future Development of Targeted Immunotherapy in Pediatric Relapsed-Refractory Acute Leukemia
por: Shalabi, Haneen, et al.
Publicado: (2015)

Discontinuation of tyrosine kinase inhibitors based on BCR-ABL1 monitoring by digital droplet PCR in pediatric chronic myeloid leukemia
por: Kim, Yeojae, et al.
Publicado: (2022)

Flow Cytometric DNA Index and Karyotype in Childhood Lymphoblastic Leukemia
por: Forestier, Erik, et al.
Publicado: (1998)

Unsupervised Flow Cytometry Analysis Allows for an Accurate Identification of Minimal Residual Disease Assessment in Acute Myeloid Leukemia
por: Vial, Jean Philippe, et al.
Publicado: (2021)

Moving Myeloid Leukemia Drug Discovery Into the Third Dimension
por: Cartledge Wolf, Donna M., et al.
Publicado: (2019)

Minimally invasive management of pediatric osteoarticular infections
por: Alcobendas, Rosa María, et al.
Publicado: (2022)

Quality Assessment of a Large Multi-Center Flow Cytometric Dataset of Acute Myeloid Leukemia Patients—A EuroFlow Study
por: Bras, Anne E., et al.
Publicado: (2022)

Quality of Response in Acute Myeloid Leukemia: The Role of Minimal Residual Disease
por: Maurillo, Luca, et al.
Publicado: (2019)

The Future of Pediatric Urology
por: Ransley, Philip
Publicado: (2019)

Targeting FLT3 Signaling in Childhood Acute Myeloid Leukemia
por: Sexauer, Amy N., et al.
Publicado: (2017)

Corrigendum: Minimally invasive management of pediatric osteoarticular infections
por: Alcobendas, Rosa María, et al.
Publicado: (2023)

Clinical and Cytometric Study of Immune Involvement in a Heterogeneous Cohort of Subjects With RASopathies and mTORopathies
por: Valencic, Erica, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rlk7ggqb6dfevlno16jdnvn9cv